Medication

Immunotherapy can now reprogram T cells, improve cancer targeting, and move more precise cell based treatments closer to routine care.

Matching cleansers, actives, and treatments to each phase of the cycle can reduce breakouts, irritation, oiliness, and sensitivity.

Hormone therapy deserves a clinical reset. Fear driven by the WHI still does not reflect the women most often evaluated during menopause today.

What real support peptides have outside GLP 1 drugs, why regulation matters, and how to judge safety, efficacy, and black market risk.

Menopause is not silence or resignation. Learn how to identify symptoms, personalize hormone care, and recover physical, mental, and sexual wellbeing.

A practical approach to improve glucose and body composition using A1c, CGM, DEXA, sleep tracking, and sustainable changes in food, stress, and training.

A practical framework for deciding which habits and drugs make sense for longevity, using risk benefit analysis, biomarkers, and caution around metformin.

A new center aims to speed CRISPR therapies for rare childhood disease. Learn the case of a treated infant and the safety steps involved.

Many peptides are marketed like supplements, but they can be unapproved drugs. Understand the rules, product quality, and your risk tolerance.

If you are considering TRT, understand the long term commitment, how to measure improvements, and which labs and side effects you should track with your doctor.

Why large scale molecule discovery can unlock longevity therapeutics and radiation resilience, and how to evaluate claims with auditable evidence.

Metformin, rapamycin, and resveratrol sound promising, but data decides. A practical guide to reading trials, spotting bias, and knowing what not to do.

A practical review of GLP-1 use in obesity and cardiometabolic health, including benefits, limits, and risk management.

How to combine diet and medication to lower cardiovascular risk, interpret LDL and coronary calcium, and discuss statins without fear or absolutes.

Practical review of low dose lithium, potential brain and aging benefits, current evidence limits, and a safety first framework for clinical decisions.